In this obesity phenotype (despite being of normal BMI), ghrelin levels were significantly higher than those in the MHO and MUO groups (Table 2), producing orexigenic effects that may depend on hypothalamic adenosine monophosphate-activated protein kinase (AMPK) activity (Scerif et al., 2010). The gene discussed is GHRL; the disease is obesity disorder.